Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Lyfgenialyfgenia.comLYFGENIA is an FDA-approved gene therapy for sickle cell disease in individuals aged 12 and older with a history of vaso-occlusive events. It is a one-time gene addition therapy that adds genetic material to the patient's own cells, eliminating the need for a donor.
Parse Score
